Vés al contingut

An interventional efficacy and safety phase 3, double-blind, 2-arm study to investigate IV followed by oral fosmanogenix compared with IV caspofungin follow by oral fluconazole in adult participants with candidemia and/or invasive cansidiasis

Obert